Group for Research in Decision Analysis

Recent papers from Group for Research in Decision Analysis

1. Effectiveness of leniolisib in reducing infections among patients with activated phosphoinositide 3-kinase δ syndrome (APDS)Immunologic Research · 2026
2. Comparative Effectiveness of Mepolizumab Versus Dupilumab in Medicare Fee-for-Service Beneficiaries with Asthma: A Real-World Cohort StudyAdvances in Therapy · 2026
3. A Team‐Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Real‐World Dosing Patterns and Persistence Among Patients With and Without a History of Methamphetamine UsePulmonary Circulation · 2026
4. Decomposition method for a capacitated single-vehicle covering tour problem with intermediate facilitiesComputers & Operations Research · 2026
5. Persistent microhematuria and risk of long-term kidney failure in adult patients with immunoglobulin A nephropathy (IgAN) in the United StatesRare Kidney Diseases · 2026
6. Real-World Effectiveness of Mepolizumab Initiation in Treating Asthma and Concurrent Chronic Obstructive Pulmonary Disease in the USPulmonary Therapy · 2026
7. Spatial pattern regression for meteorological fields interpolationHydrology and earth system sciences · 2026
8. Treatment Preferences of Physicians of Pediatric Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice ExperimentNeurology and Therapy · 2026
9. Economic advantage of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: A cost-per-responder evaluationJournal of Managed Care & Specialty Pharmacy · 2026
10. AD-MERGE 2.0: an integrated assessment of the Nexus among energy transitions, climate impacts, and adaptation responsesGeoscientific model development · 2026
11. Excellence in onboarding: a case study of campus leader support for early-career teachersEuropean journal of training and development · 2026
12. Indicators of Suboptimal Treatment Among Patients With Crohn's Disease Treated With Ustekinumab or Risankizumab and Treatment Journey Among Ustekinumab Discontinuers in the United StatesJCC Plus · 2026
13. Early real-world utilization of ADA-adaz (Hyrimoz) in the United StatesMedicine · 2026
14. Real-World Assessment of Healthcare Resource Utilization-Defined Manic and Depressive Events Among Patients with Bipolar I Disorder Treated with Cariprazine Versus AripiprazoleAdvances in Therapy · 2026
15. Epidemiology and economic burden of diagnosed congenital cytomegalovirus disease in France during the first 2 years of life: a retrospective data analysisBMC Pediatrics · 2026
16. Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database studyFrontiers in Allergy · 2026
17. Enhancing college students' financial literacy skills: An empirical investigation of complex thinking competencySocial Sciences & Humanities Open · 2026
18. A path‐based two‐commodity flow model and a branch‐price‐and‐cut algorithm for the inventory routing problem with time windowsInternational Transactions in Operational Research · 2026
19. Healthcare resource utilization and costs in patients with multiple myeloma administered ciltacabtagene autoleucel in outpatient versus inpatient settings after one to three prior lines of therapyJournal of Comparative Effectiveness Research · 2026
20. IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel TreatmentOncology and Therapy · 2026